Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
10/2009
10/14/2009CN101555245A Application of silibinin methyl ether in preparing anti-leukemia medicine
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/13/2009CA2368274C C10 ester substituted taxanes as antitumor agents
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009123948A2 Compounds and compositions as itpkb inhibitors
10/08/2009WO2009122447A1 Semi-synthetic sesquiterpene lactone parthenin compound useful for cytotoxicity against cancer cell lines and anticander agent
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009US20090253744 Acylated piperidine derivatives as melanocortin-4 receptor modulators
10/08/2009US20090253691 Trisubstituted 1,2,4-triazoles
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253118 Luminescence quenchers and fluorogenic probes for detection of reactive species
10/08/2009CA2720490A1 Compounds and compositions as itpkb inhibitors
10/08/2009CA2714051A1 Process for preparing nebivolol
10/07/2009EP2107055A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
10/07/2009EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/07/2009CN101553485A Process for preparing nebivolol
10/07/2009CN101550133A Method for extracting puerarin and usage of kudzu vine root for preparing medicament protecting liver
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/01/2009WO2009121033A2 Substituted nitrogen heterocycles and synthesis and uses thereof
10/01/2009WO2009120212A1 Method of purifying dianhydrides, the dianhydrides formed thereby, and polyetherimides formed therefrom
10/01/2009WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009US20090247766 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
10/01/2009US20090247727 Method of Purifying Dianhydrides, the Dianhydrides Formed Thereby, and Polyetherimides Formed Therefrom
10/01/2009US20090247551 Substituted enaminocarbonyl compounds
10/01/2009US20090247503 5-demethoxyfumagillol and derivatives thereof
10/01/2009CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
09/2009
09/30/2009EP2104669A2 Inhibitors of akt activity
09/30/2009EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
09/30/2009CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof
09/30/2009CN101543491A Application of m-chlorobenzoyl substituted dehydrosilybin for preparing antiviral drugs
09/24/2009WO2009116883A2 Catalytic asymetric hydrogenation
09/24/2009WO2009115557A2 Fungicide hydroximoyl-tetrazole derivatives
09/24/2009WO2009067960A3 A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates
09/24/2009US20090240071 Preparation and purification of mupirocin calcium
09/24/2009US20090239905 Piperidines and related compounds for the treatment of dementia
09/24/2009US20090239867 1-(2,4-Dimethoxybenzyl)-5-oxo-pyrrolidine-3-carboxylic Acid Methyl Ester; for treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma or baldness; prostaglandin EP2 agonists
09/24/2009US20090238969 Organic dye for recording layer and high density optical recording medium using the same
09/24/2009CA2716694A1 Process
09/23/2009EP2102196A1 Process for preparing nebivolol
09/23/2009EP2102181A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
09/23/2009CN101541791A Process for preparing nebivolol
09/22/2009US7592368 HIV aspartyl protease inhibitors; solubility, bioavailability; viral and HIV infections
09/22/2009CA2398274C Adenosine receptor modulators
09/17/2009WO2009112490A1 Sulfonamides as zap-70 inhibitors
09/17/2009CA2717529A1 Sulfonamides as zap-70 inhibitors
09/16/2009EP2099790A2 Process for preparing nebivolol
09/16/2009EP2099762A1 Antibacterial quinoline derivatives
09/16/2009EP2099753A2 Heteroarylacrylamides and their use as pharmaceuticals
09/16/2009CN100540550C Method of stabilizing macrolide compound
09/15/2009US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia
09/15/2009US7589128 Process for preparation of amorphous form of a drug
09/15/2009US7589085 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
09/11/2009WO2009111635A2 Dithiol compounds, derivatives, and uses therefor
09/11/2009WO2009111633A2 Mercaptan and seleno-mercaptan compounds and methods of using them
09/11/2009WO2009111309A1 Pesticides
09/11/2009WO2009109230A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
09/11/2009CA2717138A1 Heterocyclic compound
09/11/2009CA2717069A1 Pesticides
09/11/2009CA2715796A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
09/10/2009US20090227795 Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereof
09/09/2009CN101525332A Method for preparing stable difenoconazole technical material
09/08/2009US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
09/08/2009US7585882 Phosphodiesterase 4 inhibitors
09/08/2009US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines
09/03/2009WO2009108392A2 Catalytic enantioselective synthesis of flavanones and chromanes
09/03/2009WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists
09/03/2009WO2009058937A3 Heteroaryl ethers and processes for their preparation
09/02/2009EP2094691A1 Method for purifying dianhydrides
09/02/2009EP2094690A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
09/02/2009EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
09/02/2009EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
09/02/2009CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof
09/02/2009CN100534992C Silybin esters derivatives and preparation and use thereof
09/01/2009US7582777 from electrocoupling of polyunsaturated long chain fatty acids from oils, specifically vegetable oils, containing a terminal olefin; as biomonomer for coating compositions, thermoset plastics; reactive diluents and modifiers in latex, epoxy, alkyd and polymer compositions
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582632 Tri(cyclo) substituted amide compounds
08/2009
08/27/2009WO2009105438A1 Therapeutic substituted lactams
08/27/2009WO2009103360A1 Polyisoprenoid epoxides useful for decreasing cholesterol and/or increasing coenzyme q biosynthesis
08/27/2009US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
08/27/2009US20090215767 Isoflavone derivatives and pharmaceutical compositions comprising the same
08/27/2009US20090215740 Therapeutic substituted beta-lactams
08/27/2009US20090214444 Poly aromatic sodium channel blockers
08/26/2009EP2093222A1 Polyisoprenoid epoxides useful for decreasing cholesterol and/or increasing coenzyme Q biosynthesis
08/26/2009EP2091919A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer
08/26/2009EP1590338B1 Modulators of melanocortin receptor
08/26/2009CN101516871A Novel pyridazine derivatives
08/26/2009CN101516868A Novel pyridazine derivatives
08/26/2009CN101516864A Process for the preparation of candesartan cilexetil form I
08/26/2009CN101513402A Antiviral agent
08/26/2009CN100532375C Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical containing the compound
08/25/2009US7579488 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; [(2-{1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethylpropyl}-benzofuran-5-carbonyl)-amino]-acetic acid
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009CA2563965C 6-0-substituted ketolides having antibacterial activity
08/20/2009WO2009103007A2 Steroid hormone receptor modulator compounds and methods
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 120